Rating History for Rein Therapeutics (RNTX) by Brookline Capital Markets

More Stocks Rated by Brookline Capital Markets | Latest Ratings for RNTX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/21/2026 Kemp Dolliver Downgrade Hold
(Buy)		 N/A
(N/A)		 1.20
(0.99)		 -17.5% Details